Article Details
Retrieved on: 2017-12-28 05:45:00
Tags for this article:
Click the tags to see associated articles and topics
Excerpt
<div><b>Baupost Group</b> Llc who had been investing in Theravance Biopharma Inc for a number of months, seems to be bullish on the $1.49 billion market cap company. (NASDAQ:TBPH) rating on Wednesday, November 8. The stock has an average rating of "Hold" and an average price target of $41.86. The firm ...</div>
Article found on:
This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.
Sign UpAlready have an account? Log in here